Lucia D Notarangelo
Overview
Explore the profile of Lucia D Notarangelo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
873
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vallee T, Glasmacher J, Buchner H, Arkwright P, Behrends U, Bondarenko A, et al.
Blood
. 2024 Apr;
143(24):2504-2516.
PMID: 38579284
Wiskott-Aldrich syndrome (WAS) is a multifaceted monogenic disorder with a broad disease spectrum and variable disease severity and a variety of treatment options including allogeneic hematopoietic stem cell transplantation (HSCT)...
2.
Russo G, Parodi E, Farruggia P, Notarangelo L, Perrotta S, Casale M, et al.
Blood Transfus
. 2023 Sep;
22(3):253-265.
PMID: 37677093
Background: Immune thrombocytopenia (ITP) is an acquired immune-mediated bleeding disorder characterized by isolated thrombocytopenia. Its estimated yearly incidence in the pediatric population is 1.9-6.4/100,000. ITP in children is usually a...
3.
Cattaneo A, Liguori M, Trombetta E, Ceriotti F, Pugni L, Ronchi A, et al.
Blood Transfus
. 2022 Aug;
21(3):227-234.
PMID: 35969137
Background: In neonates, antibody-mediated destruction of neutrophils may occur as a consequence of auto- or isoimmune disorders. There are few studies on this topic, and particularly on neonatal alloimmune neutropenia...
4.
Graziadei G, De Franceschi L, Sainati L, Venturelli D, Masera N, Bonomo P, et al.
Front Med (Lausanne)
. 2022 Apr;
9:832154.
PMID: 35372393
Clinical Trial Registration: ClinicalTrials.gov, identifier: NCT03397017.
5.
Parodi E, Russo G, Farruggia P, Notarangelo L, Giraudo M, Nardi M, et al.
Blood Transfus
. 2020 Sep;
18(5):396-405.
PMID: 32931416
Background: The aim of the present study was to assess management strategies for immune thrombocytopenia (ITP) among Italian paediatric haematologists, and to compare these with those of recent international guidelines....
6.
Castaman G, Santoro C, Coppola A, Mancuso M, Santoro R, Bernardini S, et al.
Blood Transfus
. 2019 Oct;
18(2):143-151.
PMID: 31657709
Emicizumab has been approved in several countries for regular prophylaxis in patients with congenital haemophilia A and FVIII inhibitors because it substantially reduces their bleeding risk and improves quality of...
7.
Zanon E, Tagliaferri A, Pasca S, Ettorre C, Notarangelo L, Biasioli C, et al.
Blood Transfus
. 2019 Jun;
18(2):152-158.
PMID: 31184581
Background: Physical activity in people with haemophilia (PWH) reduces the development of severe arthropathy, but it must be performed after regular, proper prophylaxis. Strict adherence to treatment is crucial to...
8.
Giordano P, Grassi M, Saracco P, Luciani M, Colombini A, Testi A, et al.
J Pediatr Hematol Oncol
. 2019 Jan;
41(4):275-279.
PMID: 30640822
Objective Of The Study: In this study we aimed to retrospectively evaluate how centers, belonging to the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP), manage severe acquired hypofibrinogenemia in children...
9.
Pastrana D, Peretti A, Welch N, Borgogna C, Olivero C, Badolato R, et al.
mSphere
. 2018 Dec;
3(6).
PMID: 30541782
Several immunodeficiencies are associated with high susceptibility to persistent and progressive human papillomavirus (HPV) infection leading to a wide range of cutaneous and mucosal lesions. However, the HPV types most...
10.
Parasole R, Valsecchi M, Silvestri D, Locatelli F, Barisone E, Petruzziello F, et al.
Blood Cancer J
. 2018 Nov;
8(12):115.
PMID: 30442887
No abstract available.